Catalyst
Systematic Alpha Fund
Long-term capital appreciation with low correlation to U.S. equity markets — through a multi-risk premia strategy capturing systematic risk sources embedded in the capital markets via the BNP Paribas Catalyst Systematic Alpha Index.
Fund Objective & Access
01The Fund's objective is to seek long-term capital appreciation.
Catalyst Funds has partnered with the BNP QIS Team to create the BNP Paribas Catalyst Systematic Alpha Index℠ (the "BNPP CASA Index") — a diversified portfolio of BNPP Index Components, many of which were only known among academics and a few practitioners until recently. Track the BNPP CASA Index at casaindex.bnpparibas.com.
Why Invest in ATR?
02The Catalyst Systematic Alpha Fund seeks long-term capital appreciation with low correlation to the U.S. equity market through a multi-risk premia strategy that attempts to capture various sources of systematic risks embedded in the capital markets.
Fund Performance
03Returns >1 year annualized. Without sales load. Source: Ultimus Fund Solutions. Prior to 11/1/2017, the Fund was named Catalyst Intelligent Alternative Fund and implemented a different investment strategy. Effective July 8, 2022, the equity component managed by a previous sub-advisor is no longer a component of the Fund's portfolio; the BNP Systematic Alpha strategy remains the same.
Quarter-end data. Returns >1 year annualized. Without sales load. Prior to 11/1/2017, the Fund was named Catalyst Intelligent Alternative Fund. Effective July 8, 2022, the equity component was changed; the BNP Systematic Alpha strategy remains the same.
Fund Overview
04Fund Management
06Fund Expenses
07| Expense Item | Class I (ATRFX) | Class A (ATRAX) | Class C (ATRCX) |
|---|---|---|---|
| Prospectus Gross Expense Ratio (11/1/2025) | 1.85% | 2.11% | 2.88% |
| Prospectus Net Expense Ratio (11/1/2025) | 1.85% | 2.10% | 2.85% |
| Annual Report Net Expense Ratio (6/30/2025)* | 1.77% | 2.02% | 2.75% |
*The annual report presents the audited actual expenses of the fund for the fiscal year. It excludes the impact of certain items that are listed as prospectus expenses, such as acquired fund fees and expenses. The advisor has contractually agreed to waive advisory fees and/or reimburse expenses of the Fund to the extent necessary to limit total annual fund operating expenses (excluding brokerage costs; borrowing costs such as (a) interest and (b) dividends on securities sold short; taxes; underlying fund expenses; and extraordinary expenses, such as regulatory inquiry and litigation expenses) at 2.02%, 2.77% and 1.77% for Class A shares, Class C shares and Class I shares, respectively, through October 31, 2026.